Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein.

Chromobox protein homologue 7 (CBX7) is a chromobox family protein encoding a novel polycomb protein, the expression of which shows a progressive reduction, well related with the malignant grade of the thyroid neoplasias. Indeed, CBX7 protein levels decreased in an increasing percentage of cases going from benign adenomas to papillary, follicular, and anaplastic thyroid carcinomas. To elucidate the function of CBX7 in carcinogenesis, we searched for CBX7 interacting proteins by a proteomic analysis. By this approach, we identified several proteins. Among these proteins, we selected histone deacetylase 2 (HDAC2), which is well known to play a key role in neoplastic cell transformation and down-regulation of E-cadherin expression, the loss of which is a critical event in the epithelial-to-mesenchymal transition. We confirmed by coimmunoprecipitation that CBX7 physically interacts with the HDAC2 protein and is able to inhibit its activity. Then, we showed that both these proteins bind the E-cadherin promoter and that CBX7 up-regulates E-cadherin expression. Consistent with these data, we found a positive statistical correlation between CBX7 and E-cadherin expression in human thyroid carcinomas. Finally, we showed that the expression of CBX7 increases the acetylation status of the histones H3 and H4 on the E-cadherin promoter. Therefore, the ability of CBX7 to positively regulate E-cadherin expression by interacting with HDAC2 and inhibiting its activity on the E-cadherin promoter would account for the correlation between the loss of CBX7 expression and a highly malignant phenotype.

[1]  Catharine L. Smith.  A shifting paradigm: histone deacetylases and transcriptional activation , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  M. Kruhøffer,et al.  UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas , 2005, British Journal of Cancer.

[3]  David Beach,et al.  CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus , 2005, Oncogene.

[4]  G. Crabtree,et al.  Understanding the Words of Chromatin Regulation , 2009, Cell.

[5]  S. Hirohashi,et al.  Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. , 2002, Nucleic acids research.

[6]  C. Langford,et al.  Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. , 2007, Genome research.

[7]  Daniel Chourrout,et al.  Genome Regulation by Polycomb and Trithorax Proteins , 2007, Cell.

[8]  F. Portillo,et al.  Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.

[9]  C. Croce,et al.  HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. , 2006, Cancer cell.

[10]  Jürg Bähler,et al.  Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation , 2007, Nature.

[11]  A. Fusco,et al.  High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity , 2006, Cell Death and Differentiation.

[12]  E. Seto,et al.  Histone deacetylases and cancer , 2007, Oncogene.

[13]  D. Beach,et al.  Polycomb CBX7 has a unifying role in cellular lifespan , 2004, Nature Cell Biology.

[14]  S. Lowe,et al.  Role of the chromobox protein CBX7 in lymphomagenesis , 2007, Proceedings of the National Academy of Sciences.

[15]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[16]  C. Allis,et al.  Mouse Polycomb Proteins Bind Differentially to Methylated Histone H3 and RNA and Are Enriched in Facultative Heterochromatin , 2006, Molecular and Cellular Biology.

[17]  Jessica E. Bolden,et al.  Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.

[18]  E. Ballestar,et al.  Snail Mediates E-Cadherin Repression by the Recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex , 2004, Molecular and Cellular Biology.

[19]  Bing Li,et al.  The Role of Chromatin during Transcription , 2007, Cell.

[20]  P. Fernandez,et al.  Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. , 2001, Genes & development.

[21]  A. Lund,et al.  Polycomb complexes and silencing mechanisms. , 2004, Current opinion in cell biology.

[22]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[23]  A. Woodard,et al.  Transcriptional defects underlie loss of E-cadherin expression in breast cancer. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  E. Fearon,et al.  Cadherin and catenin alterations in human cancer , 2002, Genes, chromosomes & cancer.

[25]  P. Marks,et al.  Histone deacetylases and cancer: causes and therapies , 2001, Nature Reviews Cancer.

[26]  G. Felsenfeld,et al.  Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. , 2005, Genes & development.

[27]  A. Shevchenko,et al.  Identification of components of trans‐Golgi network‐derived transport vesicles and detergent‐insoluble complexes by nanoelectrospray tandem mass spectrometry , 1997, Electrophoresis.

[28]  John K Field,et al.  Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Fusco,et al.  One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes , 1987, Molecular and cellular biology.

[30]  Sharmistha Pal,et al.  mSin3A/Histone Deacetylase 2- and PRMT5-Containing Brg1 Complex Is Involved in Transcriptional Repression of the Myc Target Gene cad , 2003, Molecular and Cellular Biology.

[31]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[32]  S. Dhanasekaran,et al.  Repression of E-cadherin by the polycomb group protein EZH2 in cancer , 2008, Oncogene.

[33]  A. Fusco,et al.  Retraction: Identification of new high mobility group A1 associated proteins , 2007, Proteomics.

[34]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[35]  M. Szyf,et al.  Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. , 2007, Biochemical pharmacology.

[36]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[37]  S. Asa,et al.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.

[38]  J. Kruh.  Effects of sodium butyrate, a new pharmacological agent, on cells in culture , 1981, Molecular and Cellular Biochemistry.

[39]  L. Sobin,et al.  The WHO histological classification of thyroid tumors: A commentary on the second edition , 1989, Cancer.

[40]  Sharmistha Pal,et al.  Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes , 2004, Molecular and Cellular Biology.

[41]  B. van Steensel,et al.  Histone modifications: from genome-wide maps to functional insights , 2005, Genome Biology.

[42]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[43]  G. Viglietto,et al.  Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. , 2006, Cancer research.

[44]  M. Santoro,et al.  Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. , 2008, Cancer research.

[45]  E. Fearon,et al.  Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements , 1999, Oncogene.

[46]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.